ORL-1G

D-galactose · Orpha Labs

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ORL-1G, covering 2019-01-25 to 2019-01-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14 [Phase 1, Phase 2]